HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro.

Abstract
Gliomas are the most aggressive adult primary brain tumors. Expression of inducible Nitric Oxide Synthase has been reported as a hallmark of chemoresistance in gliomas and several studies have reported that inhibition of inducible Nitric Oxide Synthase could be related to a decreased proliferation of glioma cells. The present work was to analyze the molecular effects of the acetamidine derivative compound 39 (formally CM544, N-(3-{[(1-iminioethyl)amino]methyl}benzyl) prolinamide dihydrochloride), a newly synthetized iNOS inhibitor, in a C6 rat glioma cell model. There is evidence of CM544 selective binding to the iNOS, an event that triggers the accumulation of ROS/RNS, the expression of Nrf-2 and the phosphorylation of MAPKs after 3 h of treatment. In the long run, CM544 leads to the dephosphorylation of p38 and to a massive cleavage of PARP-1, confirming the block of C6 rat glioma cell proliferation in the G1/S checkpoint and the occurrence of necrotic cell death.
AuthorsMarialucia Gallorini, Cristina Maccallini, Alessandra Ammazzalorso, Pasquale Amoia, Barbara De Filippis, Marialuigia Fantacuzzi, Letizia Giampietro, Amelia Cataldi, Rosa Amoroso
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 20 Issue 3 (Jan 24 2019) ISSN: 1422-0067 [Electronic] Switzerland
PMID30678338 (Publication Type: Journal Article)
Chemical References
  • Amidines
  • Antineoplastic Agents
  • CM544
  • Enzyme Inhibitors
  • Proline
  • Nitric Oxide Synthase Type II
  • Parp1 protein, rat
  • Poly (ADP-Ribose) Polymerase-1
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Amidines (pharmacology)
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Brain Neoplasms (metabolism)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Enzyme Inhibitors (pharmacology)
  • Glioma (metabolism)
  • Nitric Oxide Synthase Type II (antagonists & inhibitors)
  • Poly (ADP-Ribose) Polymerase-1 (metabolism)
  • Proline (analogs & derivatives, pharmacology)
  • Proteolysis
  • Rats
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: